Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Head and Neck Cancer

  Free Subscription


18.05.2026

2 BMC Cancer
3 Dis Esophagus
20 Head Neck
1 Hum Pathol
1 Int J Cancer
1 J Clin Oncol
7 Laryngoscope
1 Ophthalmic Plast Reconstr Surg
3 Oral Oncol
3 Radiol Imaging Cancer
1 Radiother Oncol
1 Surgery
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. LI R, Huang HQ, Yang LH, Zhou ZY, et al
    Efficacy and safety of concurrent chemoradiotherapy combined with immunotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2026 May 11. doi: 10.1186/s12885-026-16162.
    PubMed         Abstract available

  2. YOUNG S, Moon DH, Wang J, Chen L, et al
    Involved nodal versus elective neck radiotherapy (INVERT) for head and neck squamous cell carcinoma: a prospective phase II randomized controlled trial protocol.
    BMC Cancer. 2026 May 11. doi: 10.1186/s12885-026-15904.
    PubMed         Abstract available


    Dis Esophagus

  3. HOLMEN A, Murad F, Nilsson K, Rouvelas I, et al
    Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trial.
    Dis Esophagus. 2026;39:doag047.
    PubMed         Abstract available

  4. TROTTENBERG T, Hegazy M, Astany S, Sedighi S, et al
    Esophageal Cancer Patient Network: a scalable platform for integrating patient voices across the research lifecycle.
    Dis Esophagus. 2026;39:doag046.
    PubMed         Abstract available

  5. WISSING RO, Matthee E, Baranov NS, Ubels S, et al
    Are age, comorbidity, and frailty associated with complications after minimally invasive esophagectomy? A multicenter cohort study.
    Dis Esophagus. 2026;39:doag039.
    PubMed         Abstract available


    Head Neck

  6. FIEDLER M, Baumann L, Eichberger J, Gottsauner M, et al
    A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD-1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2026 May 10. doi: 10.1002/hed.70313.
    PubMed         Abstract available

  7. CREANEY G, Gonzalez IL, Cuello M, de Aquino Goulart M, et al
    Health System Factors in Head and Neck Cancer Diagnosis: A HEADSpAcE Consortium Qualitative Study in Glasgow and Montevideo.
    Head Neck. 2026 May 10. doi: 10.1002/hed.70262.
    PubMed         Abstract available

  8. ADRIAN G, Anghede AH, McDowell L, Gebre-Medhin M, et al
    External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy.
    Head Neck. 2026 May 11. doi: 10.1002/hed.70315.
    PubMed         Abstract available

  9. PATTERSON C, Ward EC, Packer RL, Foley J, et al
    "It's the Exact Same Treatment ... Except Only 5 Min Away": A RE-AIM Evaluation of a Speech-Language Pathology Shared-Care Model for Rural Patients With Head and Neck Cancer.
    Head Neck. 2026 May 12. doi: 10.1002/hed.70311.
    PubMed         Abstract available

  10. CHEN M, Wang J, Tu L, Zheng H, et al
    Targeted Radionuclide Therapy With (131)I-Labeled Anti-PD-L1 Antibody Suppresses Pharyngeal Squamous Cell Carcinoma in the Animal Model.
    Head Neck. 2026;48:1409-1415.
    PubMed         Abstract available

  11. CHEN SF, Hu YW, Yeh CF, Chou CW, et al
    Association Between Elective Nodal Irradiation and Oncologic Outcomes in Node-Negative Olfactory Neuroblastoma and Sinonasal Squamous Cell Carcinoma: A Propensity-Score Matched Analysis.
    Head Neck. 2026;48:1437-1446.
    PubMed         Abstract available

  12. KIM JH, Moon JH, Kim CY, Jeong HN, et al
    KUSCC-192: A Novel Tonsillar Squamous Cell Carcinoma Cell Line With Mixed (Episomal and Integrated)-Typed Human Papillomavirus From a Korean Patient With Tonsil Cancer.
    Head Neck. 2026;48:1447-1460.
    PubMed         Abstract available

  13. TONDO A, Loperfido A, Re A, Crescio C, et al
    Interventional Radiotherapy (Brachytherapy) for the Treatment of the Primary Lesion in Squamous Cell Carcinomas of the Oral Vestibule.
    Head Neck. 2026;48:1491-1498.
    PubMed         Abstract available

  14. BURNS CR, Mattingly AS, Ely K, Radevic A, et al
    Intraoperative Molecular Imaging Can Detect Large Nerve Perineural Invasion: A Case Report.
    Head Neck. 2026;48:E58-E61.
    PubMed         Abstract available

  15. OLIVER JR, Wang NC, Alapati R, Attwood E, et al
    Improved Survival of HPV-Related Sinonasal Squamous Cell Carcinoma With Chemoradiation Treatment.
    Head Neck. 2026;48:1510-1518.
    PubMed         Abstract available

  16. SCHUDERER JG, Hoferer F, Eichberger J, Fiedler M, et al
    Perioperative Piperacillin/Tazobactam Reduces Early Onset SSI in Preirradiated Patients Undergoing Microvascular Head and Neck Reconstruction.
    Head Neck. 2026;48:1519-1528.
    PubMed         Abstract available

  17. CLARK DES, Bendapudi A, Haines CB, Rossi N, et al
    Exceedingly Hyper-Secreting Parathyroid Adenoma: A Literature Review and Case Series.
    Head Neck. 2026;48:1529-1536.
    PubMed         Abstract available

  18. ZHANG C, Cheng Z, Jiang X, Zhao G, et al
    Age-Related Risk Stratification in HPV-Positive Oropharyngeal Cancer: Implications for Treatment De-Intensification.
    Head Neck. 2026;48:1537-1546.
    PubMed         Abstract available

  19. BARATZ H, Renkert E, Li Y, McDaniels J, et al
    Self-Reported Speech Outcomes in Oral Cavity Cancer.
    Head Neck. 2026;48:1559-1566.
    PubMed         Abstract available

  20. VANNIER AGL, Kondamuri NS, Wu MS, Allen J, et al
    Obstructive Sleep Apnea Following Head and Neck Chemoradiation: A Scoping Review With Exploratory Meta-Analysis.
    Head Neck. 2026;48:1587-1594.
    PubMed         Abstract available

  21. SU A, King J, Belafsky P, Evangelista L, et al
    Off-Label Use of a Tracheoesophageal Prosthesis for Occlusion of an Oronasal Fistula.
    Head Neck. 2026;48:E62-E65.
    PubMed         Abstract available

  22. DONDERS DNV, Tellman RS, Schouten SM, Dankbaar JW, et al
    Limited Sensitivity of Ultrasound-Guided Fine-Needle Aspiration Cytology for Occult Nodal Metastases in Early-Stage Oral Squamous Cell Carcinoma.
    Head Neck. 2026;48:1620-1629.
    PubMed         Abstract available

  23. TANAVDE V, Tharakan A, D'Souza G, Hachem RA, et al
    Behavioral Risk Factors and Seroprevalence for Human Papillomavirus in Sinonasal Carcinoma: A Multi-Institutional Case-Control Study.
    Head Neck. 2026;48:1641-1646.
    PubMed         Abstract available

  24. HOLSINGER FC, Bedi N, Topf MC, Ernst KL, et al
    T1 Microscopic Oropharyngeal Carcinoma: Revealing the Unknown Primary Through Diagnostic TORS.
    Head Neck. 2026;48:1647-1656.
    PubMed         Abstract available

  25. SAYKALY J, Vergez S, Dupret-Bories A, Modesto A, et al
    Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma.
    Head Neck. 2026;48:1668-1676.
    PubMed         Abstract available


    Hum Pathol

  26. GOMES YM, de Castro JVA, Gomes NM, Abreu RF, et al
    Epigenetic profiling of biphenotypic sinonasal sarcoma across fusion variants and high-grade transformation.
    Hum Pathol. 2026;172:106076.
    PubMed         Abstract available


    Int J Cancer

  27. XIA X, Yan J, Xu L, Sun X, et al
    Nimotuzumab Combined With Concurrent Curative Radiotherapy and S-1 in 75 Years and Older Patients With Stage II-IVB Esophageal Squamous Cell Carcinoma: A Phase II Study.
    Int J Cancer. 2026 May 13. doi: 10.1002/ijc.70550.
    PubMed         Abstract available


    J Clin Oncol

  28. HANNA GJ, Zandberg DP, Wong DJ, Sherman E, et al
    Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trial.
    J Clin Oncol. 2026 May 8:JCO2502027. doi: 10.1200/JCO-25-02027.
    PubMed         Abstract available


    Laryngoscope

  29. SOLHAN M, Comertoglu S, Zorlu ME, Yilmaz M, et al
    Prognostic Significance of Lymph Node Parameters in Laryngeal Cancer After Laryngectomy.
    Laryngoscope. 2026 May 12. doi: 10.1002/lary.70614.
    PubMed         Abstract available

  30. KATTAR N, Hawkins A, Dewan K, Nathan CA, et al
    Does Degree of Resection Improve Survival in Laryngeal Chondrosarcomas?
    Laryngoscope. 2026;136:2403-2405.
    PubMed         Abstract available

  31. RUHLE A, Subramani R, Su J, O'Sullivan B, et al
    Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.
    Laryngoscope. 2026;136:2605-2613.
    PubMed         Abstract available

  32. WYKOFF ZA, McColl LF, Baiocchi RA, Old MO, et al
    Upper Airway Obstruction due to Kaposi Sarcoma-Presenting Sign of HIV: Case Report and Review.
    Laryngoscope. 2026;136:2631-2637.
    PubMed         Abstract available

  33. MILLS MD, Jang SS, Ogawa R, Ashworth E, et al
    Fluorescence Guidance Reduces Operative Time for Sentinel Lymph Node Biopsy in the Head and Neck.
    Laryngoscope. 2026;136:2614-2620.
    PubMed         Abstract available

  34. LEON IW, Chong DS, Barrameda BNG, Gogulapati AA, et al
    ACR-TIRADS Institution and Effect on Thyroid Surgeries in Veterans: A 10-Year Retrospective Study.
    Laryngoscope. 2026;136:2820-2826.
    PubMed         Abstract available

  35. MONTANEZ-AZCARATE V, Syed Z, Porto-Gutierrez F, Campbell B, et al
    Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer.
    Laryngoscope. 2026;136:2621-2630.
    PubMed         Abstract available


    Ophthalmic Plast Reconstr Surg

  36. MECHELS KB, Park JK, Lee HBH
    Tarsoconjunctival Rotational Flap in Second-stage Modified Hughes Reconstruction for Lower Eyelid Full-thickness Defects.
    Ophthalmic Plast Reconstr Surg. 2025 Sep 11. doi: 10.1097/IOP.0000000000003060.
    PubMed         Abstract available


    Oral Oncol

  37. GAUDUCHON T, Digue L, Ferlay C, Treilleux I, et al
    Efficacy of buparlisib according to PIK3CA mutation status in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter phase II trial.
    Oral Oncol. 2026;178:108004.
    PubMed         Abstract available

  38. LY S, Ruhle A, Bratman S, Cho J, et al
    Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.
    Oral Oncol. 2026;178:108006.
    PubMed         Abstract available

  39. GRIFFIN C, Donovan ML, Lawler C, Da Gama Duarte J, et al
    Tertiary lymphoid structures in head and neck squamous cell carcinoma as predictors of response to immunotherapy.
    Oral Oncol. 2026;178:107998.
    PubMed         Abstract available


    Radiol Imaging Cancer

  40. DOU Y, Xiang Z, Song H, Wang Y, et al
    Identification of Papillary Thyroid Carcinoma in Indeterminate Nodules.
    Radiol Imaging Cancer. 2026;8:e260064.
    PubMed        

  41. XIE X, Ning Z, Hu H, Chen J, et al
    CT-based Extranodal Extension for Nodal Staging and Prognostic Stratification in Surgically Resectable Esophageal Squamous Cell Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250562.
    PubMed         Abstract available

  42. REN H, Shi D, Wang X, Xu Q, et al
    Time-dependent Diffusion MRI for Predicting Response to Induction Chemotherapy in Nasopharyngeal Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250579.
    PubMed         Abstract available


    Radiother Oncol

  43. YANG SS, Zhao YN, He Y, Liu YB, et al
    Deep learning for detection and automatic visualization of radiation-induced temporal lobe injury in nasopharyngeal carcinoma across endemic and non-endemic areas in China.
    Radiother Oncol. 2026 May 13:111596. doi: 10.1016/j.radonc.2026.111596.
    PubMed         Abstract available


    Surgery

  44. SUN H, Li S, Mao Y, Yan L, et al
    Long-term outcomes of radiofrequency ablation versus surgery for bilateral multifocal (
    Surgery. 2026;195:110247.
    PubMed         Abstract available


    Thyroid

  45. ROBERTS TJ, Meador CB, Fuld AD, Lasko A, et al
    A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib.
    Thyroid. 2026 May 12:10507256261448706. doi: 10.1177/10507256261448706.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum